Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Central nervous system tissue repair via engraftment and differentiation refers to a therapeutic strategy and biological process rather than a molecular or receptor target. It involves the transplantation (engraftment) of neural stem cells (NSCs), mesenchymal stem cells (MSCs), or other progenitor cells into damaged CNS tissue, where these cells may differentiate into neurons, glia, or other supportive cells and contribute to tissue repair. This approach aims to replace lost or damaged cells, promote regeneration (such as axon growth and remyelination), modulate the local immune response, and restore function in diseases or injuries like spinal cord injury, stroke, and multiple sclerosis. It is a complex, multifactorial intervention involving cell biology, tissue engineering, intrinsic neuronal pathways (e.g., PI3K/PTEN/mTOR, JAK/STAT), and the modulation of the extracellular environment. Since it is a procedural approach rather than a discrete druggable molecular target, it does not fit the conventional definition of a therapeutic target such as a receptor, enzyme, or ion channel[1][2][4][5][6]. Key clarifications: This entry does not correspond to a specific molecular target (e.g., receptor/protein), but describes a general tissue repair approach/process using cell transplantation and differentiation in the CNS. Designating it as a "target" would be incorrect; it is a strategy or therapeutic modality and not suitable for standard target-based structured data models. The field is highly active, and ongoing research is identifying specific molecular signals and pathways involved in the success or failure of these repair techniques, but those should be specified individually (e.g., "Neural stem cell" or "PTEN" as targets) rather than this overall process[2][5].
Cell transplantation (neural stem or progenitor cells engraft and differentiate), Promotion of axonal regrowth, Secretion of neurotrophic factors, Immunomodulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Central nervous system tissue repair via engraftment and differentiation.